Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer – toxicities and response assessment

References

• SauerRBeckerHHohenbergerWPreoperative versus postoperative chemoradiotherapy for rectal cancerN Engl J Med2004351171731174015496622
   PubMed Web of Science ®Google Scholar
• BossetJFMeneveauNPavyJJLes complications intestinales tardives de la radiothérapie adjuvante des cancers rectaux [Late intestinal complications of adjuvant radiotherapy of rectal cancers]Cancer Radiother199716770774 French9614893
   PubMedGoogle Scholar
• NuttingCMConveryDJCosgroveVPRowbottomCPadhaniARWebbSDearnaleyDPReduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancerInt J Radiat Oncol Biol Phys200048364965611020560
   PubMed Web of Science ®Google Scholar
• PortelanceLChaoKSGrigsbyPWBennetHLowDIntensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and paraaortic irradiationInt J Radiat Oncol Biol Phys200151126126611516876
   PubMed Web of Science ®Google Scholar
• RoeskeJCLujanARotmenschJWaggonerSEYamadaDMundtAJIntensity-modulated whole pelvic radiation therapy in patients with gynecologic malignanciesInt J Radiat Oncol Biol Phys20004851613162111121668
   PubMed Web of Science ®Google Scholar
• MyersonRJGarofaloMCEl NaqaIElective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlasInt J Radiat Oncol Biol Phys200974382483019117696
   PubMed Web of Science ®Google Scholar
• CoxJDStetzJPajakTFToxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)Int J Radiat Oncol Biol Phys1995315134113467713792
   PubMed Web of Science ®Google Scholar
• EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer2008452228247
   Web of Science ®Google Scholar
• WashingtonMKBerlinJBrantonPProtocol for the examination of specimens from patients with primary carcinoma of the colon and rectumArch Pathol Lab Med2009133101539155119792043
   PubMed Web of Science ®Google Scholar
• HongTSMoughanJGarofaloMCNRG Oncology Radiation Therapy Oncology Group 0822: a Phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancerInt J Radiat Oncol Biol Phys2015931293626163334
   PubMed Web of Science ®Google Scholar
• EngelsBPlatteauxNVan den BeginRPreoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcomeRadiother Oncol2013110115515924239243
   PubMed Web of Science ®Google Scholar
• Hernando-RequejoOLopezMCubilloAComplete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiationStrahlenther Onkol2014190651552024715243
   PubMed Web of Science ®Google Scholar
• CubilloAHernando-RequejoOGarcia-GarciaEA prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancerAm J Clin Oncol2012372117121
   Web of Science ®Google Scholar
• ZhuJLiuFGuWConcomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II studyRadiat Oncol201497024606870
   PubMed Web of Science ®Google Scholar
• ZhuJLianPLiuFPhase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinomaRadiat Oncol201381023295152
   PubMed Web of Science ®Google Scholar
• HuangMYChenCFHuangCMHelical tomotherapy combined with capecitabine in the preoperative treatment of locally advanced rectal cancerBiomed Res Int2014201435208324949438
   PubMed Web of Science ®Google Scholar
• ArbeaLMartinez-MongeRDiaz-GonzalezJAFour-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trialInt J Radiat Oncol Biol Phys201183258759322079731
   PubMed Web of Science ®Google Scholar
• AristuJJArbeaLRodriguezJPhase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancerInt J Radiat Oncol Biol Phys200871374875518164861
   PubMed Web of Science ®Google Scholar
• BallonoffAKavanaghBMcCarterMPreoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trialAm J Clin Oncol200831326427018525306
   PubMed Web of Science ®Google Scholar
• FreedmanGMMeropolNJSigurdsonERPhase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancerInt J Radiat Oncol Biol Phys20076751389139317394942
   PubMed Web of Science ®Google Scholar
• Gasent BlesaJMGarde NogueraJLaforga CanalesJBPhase II trial of concomitant neoadjuvant chemotherapy with oxaliplatin and capecitabine and intensity-modulated radiotherapy (IMRT) in rectal cancerJ Gastrointest Cancer201243455356122371167
   PubMedGoogle Scholar
• LiJLJiJFCaiYPreoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trialRadiother Oncol201110214921903285
   PubMed Web of Science ®Google Scholar
• RichettiAFogliataAClivioANeo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experienceRadiat Oncol201051420170490
   PubMed Web of Science ®Google Scholar
• ZhuJGuWLianPA phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/ III rectal adenocarcinomaRadiat Oncol2013813023718210
   PubMed Web of Science ®Google Scholar
• ParekhATruongMTPashtanIAcute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancerGastrointest Cancer Res201365–613714324312687
   PubMedGoogle Scholar
• JabbourSKPatelSHermanJMIntensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visitsInt J Surg Oncol2012201289106722934164
   PubMedGoogle Scholar
• YangTJOhJHSonCHApteADeasyJOWuAGoodmanKAPredictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancerGastrointest Cancer Res201365–612913624312686
   PubMedGoogle Scholar
• SamuelianJMCallisterMDAshmanJBYoung-FadokTMBoradMJGundersonLLReduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancerInt J Radiat Oncol Biol Phys20128251981198721477938
   PubMed Web of Science ®Google Scholar
• NgSYColbornKLCambridgeLHajjCYangTJWuAJGoodmanAKAcute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancerRadiother Oncol2016121225225727751605
   PubMed Web of Science ®Google Scholar
• WongSJWinterKMeropolNJRadiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancerInt J Radiat Oncol Biol Phys20128241367137521775070
   PubMed Web of Science ®Google Scholar
• PetrelliFSgroiGSartiEBarniSIncreasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studiesAnn Surg2016263345846424263329
   PubMed Web of Science ®Google Scholar
• YuHChenWCaiYPretreatment serum CEA as a predictive biomarker for the response to neoadjuvant chemoradiotherapy: a meta-analysis in rectal cancerJ Carcinog Mutagen20156237
   Google Scholar
• FilizAISuculluIKurtYKarakasDOGulecBAkinMLPersistent high postoperative carcinoembryonic antigen in colorectal cancer patients – is it important?Clinics (Sao Paulo)200964428729419488584
   PubMed Web of Science ®Google Scholar